Front-line treatment for symptomatic multiple myeloma patients.
FORMULATIONS:
Each vial contains 3.5 mg Bortezomib in a formulation as sterile lyophilized powder for reconstitution.
The material on this website is oriented to healthcare professionals only. It aims to provide information on how to use these medications efficiently, and to spread the knowledge of these products. This information does not substitute medical diagnosis, advice and indication. Biosidus recommends asking a doctor first.
The texts referring to our prescription drugs abide by the National Administration of Drugs, Foods and Medical Devices (ANMAT) in the Argentine Republic approved guidelines.